Anchorage Capital Group, L.L.C. Roivant Sciences Ltd. Transaction History
Anchorage Capital Group, L.L.C.
- $230 Million
- Q1 2025
A detailed history of Anchorage Capital Group, L.L.C. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Anchorage Capital Group, L.L.C. holds 4,832,642 shares of ROIV stock, worth $56.3 Million. This represents 21.21% of its overall portfolio holdings.
Number of Shares
4,832,642
Previous 4,832,642
-0.0%
Holding current value
$56.3 Million
Previous $57.2 Million
14.71%
% of portfolio
21.21%
Previous 22.39%
Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
345Shares Held
495MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$766 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$721 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$536 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$475 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$419 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.21B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...